Bladder Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Bladder Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab after surgery for localized muscle-invasive bladder cancer and locally advanced urothelial cancer is …
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial investigating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced urotheli…
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced urothelial …
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC [Phase 1]
A Phase 1 clinical trial update evaluating propranolol in combination with tislelizumab and gemcitabine/cisplatin as neoadjuvant therapy for…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer [Phase 2]
This Phase 2 trial update tests atezolizumab with or without eribulin mesylate in patients with recurrent locally advanced or metastatic uro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors [Phase 1]
Phase 1 trial evaluating cabozantinib S-malate with nivolumab, with or without ipilimumab, in patients with metastatic genitourinary tumors;…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer [Phase 2]
A Phase 2 trial evaluating radiation therapy with cemiplimab, with or without fianlimab, in bladder urothelial carcinoma. The study status i…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial [Phase 2]
Phase 2 INSPIRE trial evaluating whether adding durvalumab to chemotherapy and radiation improves outcomes in bladder urothelial carcinoma w…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors [Phase 2]
Phase 2 monotherapy trial of tovorafenib (DAY101) in melanoma and other solid tumors was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy [EARLY_Phase 1]
Early-phase 1 trial evaluating Copper-64 TP3805 PET/CT imaging for bladder urothelial carcinoma in patients undergoing surgery or biopsy. Th…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL) [Phase 3]
NAUTICAL is a Phase 3 neoadjuvant trial for upper tract invasive cancer, currently recruiting; the listed conditions include bladder cancer …
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer [EARLY_Phase 1]
This early-phase 1 trial update reports completion of a study evaluating daratumumab in patients with muscle-invasive bladder cancer and met…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 trial exploring bladder-preserving therapy with sacituzumab govitecan plus zimberelimab for muscle-invasive bladder cancer; the stud…
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial assessing acupuncture for treating adverse events related to intravesical BCG in high-risk non-muscle invasive bladde…
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer [Phase 2]
This Phase 2 trial evaluated cisplatin and gemcitabine with or without berzosertib in patients with metastatic urothelial cancer. The study …
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer [Phase 2]
Phase 2 trial evaluating durvalumab in combination with standard chemotherapy before surgery for variant histology bladder cancers; study te…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo [Phase 2]
Phase 2 trial evaluating nivolumab with radiotherapy in localized/locally advanced urothelial bladder cancer patients ineligible for chemoth…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma [Phase 4]
Phase 4 clinical study evaluating disitamab vedotin with penpulimab as neoadjuvant therapy for HER2-expressing cisplatin-intolerant bladder …
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma [Phase 4]
Phase 4 trial update investigating probiotics as an adjunct to immunotherapy for bladder urothelial carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-09-30Clinical Trial Update: Safety and Efficacy of Toripalimab for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma [Phase 2]
Phase 2 trial investigating safety and efficacy of toripalimab in locally advanced or metastatic bladder urothelial carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer [Phase 3]
Phase 3 trial evaluating gemcitabine hydrochloride and cisplatin with or without bevacizumab in advanced urothelial carcinoma/metastatic uro…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating gemcitabine hydrochloride and eribulin mesylate in advanced or unresectable bladder, ureter, and urethral …
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer [Phase 1, Phase 2]
A clinical trial evaluating paclitaxel with radiation therapy with or without trastuzumab in bladder cancer patients post-surgery, with phas…
-
CLINICAL_TRIALS withdrawal · 2016-04-18Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder Cancer [Phase 2]
Phase 2 trial evaluating nab-paclitaxel after cisplatin-based chemotherapy and surgery for high-risk bladder cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy [Phase 1]
This Phase 1 trial evaluating neoadjuvant intravesical vaccine therapy for bladder cancer patients undergoing cystectomy has been terminated…